All studies
(sglt2)
Longevity
12 / 29 / 2025•12 MIN READ
Top 10 Longevity & Anti-Aging Breakthroughs of 2025: What the Year Taught Us About Extending Human Healthspan
Metabolism
11 / 01 / 2025•8 MIN READ
SGLT-2 Inhibitors: Do They Differ in Their Potential for Healthspan Extension?
Longevity
06 / 21 / 2025•29 MIN READ
The Case for Cyclical Longevity Protocols: How Rhythmic Activation of AMPK and Autophagy Reprograms Aging Cells
Brain
06 / 07 / 2025•20 MIN READ
The Energy Equation in Alzheimer’s Disease: Glucose-Driven Degeneration and Ketone-Driven Protection
Longevity
05 / 30 / 2025•32 MIN READ
The Mitochondrial Signature of Long COVID: What PRDX3 Is Trying to Tell Us—And How We Might Reverse It
Metabolism
04 / 26 / 2025•14 MIN READ
Pharmacological Fasting: How SGLT-2 Inhibitors Emulate Caloric Restriction to Target Key Longevity Pathways
Metabolism
03 / 08 / 2025•28 MIN READ
SGLT2 Inhibitors as Metabolic Senolytics: Clearing Senescent Cells to Combat Pathological Aging
Brain
02 / 08 / 2025•19 MIN READ
Alzheimer’s Disease as Type 3 Diabetes: Evidence for Insulin Resistance and Metabolic Dysfunction as Drivers of AD Pathogenesis
Metabolism
01 / 25 / 2025•21 MIN READ
Mitochondria’s Paradoxical Role in Cancer Biology: Exploiting Metabolic Vulnerabilities for Therapeutic Targeting
Metabolism
01 / 18 / 2025•28 MIN READ
SGLT-2 Inhibitors in Aging and Healthspan: Surprising Mechanistic Insights Into Adipose Tissue Reduction, Lean Mass Preservation, and Longevity